Human RANKL Monoclonal Antibody
Produktgrößen
1 mg
£268,00
YR0036-1MG
5 mg
£746,00
YR0036-5MG
20 mg
£1442,00
YR0036-20MG
Über dieses Produkt
- SKU:
- YR0036
- Zusätzliche Namen:
- OPGL|RANKL|TNFSF11
- Anwendung:
- Block/Inhibit/Neutralise, Cell-based/Functional Assay, ELISA
- Klonalität:
- Monoclonal
- Weitere Details:
- Denosumab, a fully human monoclonal antibody, inhibits the RANKL (RANK ligand) protein, the primary signal for bone removal. Denosumab can be used for the treatment of osteoporosis, treatment-induced bone loss, bone metastases, multiple myeloma, and giant cell tumor of bone.
- Formulierung:
- Purified from cell culture supernatant in an animal-free facility
- Immunogen:
- Human RANK Ligand
- Isotyp:
- IgG2, kappa
- Molekulargewicht:
- 150 kDa
- Reinheit:
- >95%
- Versandbedingungen:
- Blue Ice
- Lagerbedingungen:
- 2-8[o]C Avoid freeze/thaw cycles., -70[o]C Avoid freeze/thaw cycles.
- Hersteller:
- ABclonal Technology
- Typ:
- Antibody: Biosimilar Antibody
- Datenblatt des Herstellers:YR0036